121 related articles for article (PubMed ID: 8060227)
1. In situ hybridization for the Y chromosome reveals a donor origin for a posttransplant lymphoproliferative disorder in a sex-mismatched hepatic allograft.
Hegele RG; Bicknell SG; Bailey DJ; Cameron RG
Arch Pathol Lab Med; 1994 Aug; 118(8):795-6. PubMed ID: 8060227
[TBL] [Abstract][Full Text] [Related]
2. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
3. Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Shintaku IP; Rosenthal J; Said JW
Arch Pathol Lab Med; 1998 Aug; 122(8):708-14. PubMed ID: 9701332
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
5. Post-transplantation lymphoproliferative disorder of donor origin in a sex-mismatched renal allograft as proven by chromosome in situ hybridization.
Cheung AN; Chan AC; Chung LP; Chan TM; Cheng IK; Chan KW
Mod Pathol; 1998 Jan; 11(1):99-102. PubMed ID: 9556430
[TBL] [Abstract][Full Text] [Related]
6. Donor or recipient origin of post-transplantation lymphoproliferative disorders: evaluation by in situ hybridization.
Le Frère-Belda MA; Martin N; Gaulard P; Zafrani ES
Mod Pathol; 1997 Jul; 10(7):701-7. PubMed ID: 9237181
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation.
Hruban RH; Long PP; Perlman EJ; Hutchins GM; Baumgartner WA; Baughman KL; Griffin CA
Am J Pathol; 1993 Apr; 142(4):975-80. PubMed ID: 7682765
[TBL] [Abstract][Full Text] [Related]
8. EBV-positive B cell cerebral lymphoma 12 years after sex-mismatched kidney transplantation: post-transplant lymphoproliferative disorder or donor-derived lymphoma?
Phelan PJ; Murphy RK; Farrell M; O'Toole O; Heffernan J; O'Brien D; Breathnach O; Conlon PJ
Nephrol Dial Transplant; 2010 Jun; 25(6):2032-5. PubMed ID: 20348150
[TBL] [Abstract][Full Text] [Related]
9. Systemic chimerism in sex-mismatched liver transplant recipients detected by fluorescence in situ hybridization.
Nagler A; Ilan Y; Amiel A; Eid A; Tur-Kaspa R
Transplantation; 1994 May; 57(10):1458-61. PubMed ID: 8197608
[TBL] [Abstract][Full Text] [Related]
10. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes.
Hove WR; van Hoek B; Bajema IM; Ringers J; van Krieken JH; Lagaaij EL
Liver Transpl; 2003 Jun; 9(6):552-6. PubMed ID: 12783394
[TBL] [Abstract][Full Text] [Related]
11. Donor origin of a posttransplant liver allograft malignancy identified by fluorescence in situ hybridization for the Y chromosome and DNA genotyping.
Donovan JA; Simmons FA; Esrason KT; Jamehdor M; Busuttil RW; Novak JM; Grody WW
Transplantation; 1997 Jan; 63(1):80-4. PubMed ID: 9000665
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
13. Recipient-derived hepatocytes in liver transplants: a rare event in sex-mismatched transplants.
Fogt F; Beyser KH; Poremba C; Zimmerman RL; Khettry U; Ruschoff J
Hepatology; 2002 Jul; 36(1):173-6. PubMed ID: 12085362
[TBL] [Abstract][Full Text] [Related]
14. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
[TBL] [Abstract][Full Text] [Related]
15. Does endothelial chimerism correlate with renal allograft rejection?
Bai HW; Shi BY; Qian YY; Na YQ; Cai M; Zeng X; Zhong DR; Wu SF; Chang JY; Zhou WQ
Transplant Proc; 2006 Dec; 38(10):3430-3. PubMed ID: 17175294
[TBL] [Abstract][Full Text] [Related]
16. [Posttransplant lymphoproliferative disorder].
Oike F; Egawa H; Haga H; Kudo T
Nihon Rinsho; 2006 Mar; 64 Suppl 3():639-46. PubMed ID: 16615551
[No Abstract] [Full Text] [Related]
17. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
[TBL] [Abstract][Full Text] [Related]
18. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
19. Follicular lymphoma following liver transplantation: report of a unique case with review of the literature.
Racz MM; Link BK; Vasef MA
Transplant Proc; 2004 Nov; 36(9):2782-6. PubMed ID: 15621149
[TBL] [Abstract][Full Text] [Related]
20. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
